Fulton Breakefield Broenniman’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1M | Buy |
86,951
+289
| +0.3% | +$53.6K | 1.09% | 27 |
|
|
2025
Q1 | $18.2M | Sell |
86,662
-3,049
| -3% | -$639K | 1.31% | 22 |
|
|
2024
Q4 | $15.9M | Sell |
89,711
-1,053
| -1% | -$187K | 1.14% | 28 |
|
|
2024
Q3 | $17.9M | Sell |
90,764
-3,730
| -4% | -$737K | 1.25% | 24 |
|
|
2024
Q2 | $16.2M | Sell |
94,494
-1,259
| -1% | -$216K | 1.2% | 27 |
|
|
2024
Q1 | $17.4M | Sell |
95,753
-1,250
| -1% | -$228K | 1.34% | 26 |
|
|
2023
Q4 | $15M | Sell |
97,003
-541
| -0.6% | -$83.8K | 1.21% | 34 |
|
|
2023
Q3 | $14.5M | Buy |
97,544
+586
| +0.6% | +$87.4K | 1.26% | 29 |
|
|
2023
Q2 | $13.1M | Buy |
96,958
+2,308
| +2% | +$311K | 1.08% | 40 |
|
|
2023
Q1 | $15.1M | Buy |
94,650
+1,168
| +1% | +$186K | 1.3% | 33 |
|
|
2022
Q4 | $15.1M | Buy |
93,482
+2,174
| +2% | +$351K | 1.34% | 33 |
|
|
2022
Q3 | $12.3M | Sell |
91,308
-282
| -0.3% | -$37.8K | 1.15% | 37 |
|
|
2022
Q2 | $14M | Sell |
91,590
-1,003
| -1% | -$154K | 1.21% | 36 |
|
|
2022
Q1 | $15M | Buy |
92,593
+17,785
| +24% | +$2.88M | 1.32% | 31 |
|
|
2021
Q4 | $10.1M | Sell |
74,808
-664
| -0.9% | -$89.9K | 0.75% | 51 |
|
|
2021
Q3 | $8.14M | Buy |
75,472
+109
| +0.1% | +$11.8K | 0.7% | 52 |
|
|
2021
Q2 | $8.49M | Buy |
75,363
+1,806
| +2% | +$203K | 0.73% | 51 |
|
|
2021
Q1 | $7.96M | Buy |
73,557
+12,007
| +20% | +$1.3M | 0.74% | 53 |
|
|
2020
Q4 | $6.6M | Buy |
61,550
+57,414
| +1,388% | +$6.15M | 0.79% | 52 |
|
|
2020
Q3 | $362K | Hold |
4,136
| – | – | 0.04% | 133 |
|
|
2020
Q2 | $406K | Sell |
4,136
-329
| -7% | -$32.3K | 0.05% | 123 |
|
|
2020
Q1 | $340K | Sell |
4,465
-663
| -13% | -$50.5K | 0.05% | 115 |
|
|
2019
Q4 | $454K | Buy |
5,128
+689
| +16% | +$61K | 0.05% | 123 |
|
|
2019
Q3 | $336K | Buy |
+4,439
| New | +$336K | 0.04% | 129 |
|